# Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.

> **NCT00401960** · PHASE4 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 6 (actual)

## Conditions studied

- Endocarditis, Bacterial

## Interventions

- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT00401960
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** inadequate enrollment
- **Last updated:** 2017-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401960, "Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00401960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*